171 related articles for article (PubMed ID: 35031847)
1. The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registry.
Gupta L; Nune A; Naveen R; Verma R; Prasad P; Kharbanda R; Rathore U; Rai MK; Singh MK; Anuja AK; Agarwal V
Rheumatol Int; 2022 Jul; 42(7):1143-1154. PubMed ID: 35031847
[TBL] [Abstract][Full Text] [Related]
2. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M
Front Immunol; 2022; 13():866701. PubMed ID: 35603214
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
5. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
[TBL] [Abstract][Full Text] [Related]
6. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
7. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy.
Douglass-Molloy H; Limaye V
Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772
[TBL] [Abstract][Full Text] [Related]
8. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
10. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
12. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
13. Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy.
Hou Y; Shao K; Yan Y; Dai T; Li W; Zhao Y; Li D; Lu JQ; Norman GL; Yan C
J Neurol; 2022 Jan; 269(1):280-293. PubMed ID: 34021410
[TBL] [Abstract][Full Text] [Related]
14. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
15. Statin-associated immune-mediated necrotizing myositis in Native Americans.
Muruganandam M; Iqbal A; Akpan EB; Dolomisiewicz AC; Waters YM; Emil NS; Nunez SE; McElwee MK; O'Sullivan FX; Fields RA; Sibbitt WL
Rheumatology (Oxford); 2022 Nov; 61(12):4855-4862. PubMed ID: 35348616
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
17. Anti-HMGCR myopathy: barriers to prompt recognition.
Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E
Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213
[TBL] [Abstract][Full Text] [Related]
18. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
19. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW
Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125
[TBL] [Abstract][Full Text] [Related]
20. Anti-HMGCR antibodies in systemic sclerosis.
Hudson M; Luck Y; Stephenson M; Choi MY; Wang M; Baron M; Fritzler MJ;
Medicine (Baltimore); 2016 Nov; 95(44):e5280. PubMed ID: 27858897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
